Skip to main content
. 2019 Aug 14;19:809. doi: 10.1186/s12885-019-5971-z

Fig. 3.

Fig. 3

PFS according to EOT CD4, and according to EOT MRD levels. (A) PFS curves according to EOT CD4 status in patients with undetectable (< 10−4) EOT MRD (p = 0.6998). (B) PFS curves according to EOT CD4 status in patients with detectable (≥10− 4) EOT MRD (p = 0.0004)